UNSPSC 51313112: Cetirizine hydrochloride

This classification denotes a histamine-1 receptor antagonist with the molecular formula C21H25ClN2O3.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 64O047KTOA, chemically known as acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride, (+-)- but more generally known as cetirizine dihydrochloride, which bears US NIH Compound Identifier 55182.

UNSPSC 51313112 Cetirizine hydrochloride, a Commodity code, does not match the state and local procurement activity currently posted under it. The three recent opportunities tagged to this code solicit naloxone and drug deactivation systems (Seminole County), direct-to-manufacturer prescription programs (Texas HHS Commission), and generic multi-source pharmaceuticals and OTC products through a cooperative purchasing vehicle (Minnesota Multistate Cooperative Purchasing Alliance), none of which are cetirizine-specific products or services. The mismatch suggests either miscoding in the source system or the code's use as a placeholder for broader pharmaceutical procurement without product-level specificity.

The issuing bodies reflect a mix of county health departments, state health and human services agencies, and cooperative purchasing alliances spanning multiple states. Seminole County, Florida, issued an IFB on June 30, 2026, with a response deadline of July 26, 2023, for 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries. The Texas Health and Human Services Commission posted an RFI on April 3, 2026, to gather vendor capabilities for direct-to-manufacturer prescription programs without a formal competitive timeline. The Minnesota Department of Administration issued an RFP through MMCAP on January 20, 2026, with a March 26, 2026, response deadline, seeking generic pharmaceuticals and OTC products distributed across multiple states including Oregon through three authorized wholesalers. Geographic activity centers on Florida, Texas, and Minnesota, with multi-state distribution through the MMCAP cooperative. The code shows no recent activity directly aligned with cetirizine procurement.